secwatch.observer — SEC 8-K summary
======================================

Issuer:     Profound Medical Corp. (PROF)
CIK:        0001628808
Form:       8-K
Filed at:   2026-07-15T12:00:32+00:00
Accession:  0001171843-26-004654
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Profound Medical's TULSA Procedure to be featured at SRS Annual Meeting July 23-26
--------------------------------------------------------------------------------

- TULSA Procedure highlighted in multiple presentations at SRS2026 in Fort Lauderdale, FL.
- CAPTAIN randomized trial comparing TULSA vs. radical prostatectomy: primary safety outcomes presented July 24.
- Real-world outcomes from multicenter post-market registry presented by UT Southwestern.
- Profound selected as one of eight companies for Society of Incisionless Surgery plenary session.
- Management to participate in investor session on July 22 moderated by Stifel and Wells Fargo analysts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628808/000117184326004654/0001171843-26-004654-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628808/000117184326004654/f8k_071526.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-004654

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer